LDL apheresis: A novel technique (LIPOCOLLECT 200)

Artificial Organs

Volumn 33, Issue 12, 2009, Pages 1103-1108

  Stefanutti, Claudia ^a   Di Giacomo, Serafina ^a   Mazzarella, Bruno ^a   Castelli, Alessandro ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Adsorption; Cholesterol; Coronary heart disease; Hyper Lp(a) lipoproteinemia; Hypercholesterolemia; Low density lipoprotein; Lp(a) apheresis

Indexed keywords

CARDIOLOGY; CHOLESTEROL; DISEASES; HEART; LIPOPROTEINS;

% REDUCTIONS; (LDL) LIPOPROTEIN(A) APHERESIS; ADSORBERS; CORONARY HEART DISEASE; HIGH-DENSITY LIPOPROTEIN CHOLESTEROLS; HYPER (LDL) LIPOPROTEIN(A) LIPOPROTEINEMIA; HYPERCHOLESTEROLEMIA; LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEINS; NOVEL TECHNIQUES;

ADSORPTION;

ADSORBENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOCOMPATIBILITY; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISEASE COURSE; HUMAN; HYPERLIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 74049141465     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00959.x     Document Type: Article

References (20)

1. De Gennes JL, Touraine R, Maunand B, Truffert J, Laudat P. Homozygous cutaneo-tendineous form of hypercholesterolemic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment. Bull Mem Soc Med Hop Paris 1967 118 : 1377 1402.
2. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolemia. Lancet 1975 1 : 1208 1211.
3. Thompson GR. LDL-apheresis. Atherosclerosis 2003 167 : 1 13.
4. Bosch T, Wendler T. State of art of LDL-apheresis in the year 2003. Ther Apher Dial 2004 8 : 76 9.
5. Stefanutti C, Di Giacomo S, Vivenzio A. Comparison between different techniques of LDL-apheresis. Int J Artif Organs 1997 21 (S-6 66 71.
6. Krebs A, Krebs K, Keller F. Retrospective comparison of 5 different methods for long term LDL-apheresis in 20 patients between 1986 and 2001. Int J Artif Organs 2004 27 : 137 148.
7. Poli L, Busnach G. Whole blood selective LDL-apheresis: a comparison of two different adsorbers. Int J Art Organs 2006 29 : 726 732.
8. Yamamoto A, Harada-Shiba M, Kawaguchi A, Tsushima M. Apheresis technology for prevention and regression of atherosclerosis. Ther Apher 2001 5 : 221 225.
9. Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 1996 276 : 544 548.
10. Keller C. Apheresis in coronary heart disease with elevated Lp(a): a review of Lp(a) as a risk factor and its management. Ther Apher Dial 2007 11 : 2 8.
11. Borberg H, Grewe V, Sawatzki C, Oette K, Stoffel W. Specific continuous-flow immunoabsorption ex vivo in patients with familial hypercholesterinemia. Int J Artif Organs 1981 4 : 259
12. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low-density lipoprotein in familial hypercholesterolemia. Lancet 1981 2 : 1005 1007.
13. Thies K. Selective removal of low-density lipoproteins from plasma by polyacrylate-coated Fractogel in vitro and in experimental extracorporeal perfusion. Artif Organs 1988 12 : 320 324.
14. Pokrovsky SN, Adamova IY, Afanasieva O, Benevolenskaya GF. Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study. Artif Organs 1991 15 : 136 140.
15. Pokrovsky S, Straube R, Afanasieva O, Kukharchuk V, Konovalov G. Lp(a) apheresis for the treatment of severe CHD patients with Lp(a) hyperlipidemia. Ther Apher Dial 2005 9 : A40.
16. Bambauer R, Schiel R, Klinkmann J, Latza R. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels. J Clin Apher 1998 11 : 78 80.
17. Schenck Ch, Keller S, Hailer S, Wolfram G, Zöllner N. Reduction of Lp(a) by different methods of plasma exchange. J Mol Med 1988 66 : 1197 1201.
18. Journal of the American Heart Association. New Cholesterol Treatment Guidelines: ATP III Guideline Summary of Updates. Available at: http://www.nhlbi.nih.gov/new/press/04-07-12.htm
19. Szczepiorkowski ZM, Bandarenko N, Kim HC. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007 22 : 106 175.
20. Bláha M, Cermanová M, Bláha V, et al. Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia. Ther Apher Dial 2007 11 : 9 15.